RE:Zenvesting.........I agree fundamentally on everything you say about the strength of the case Microbix has; but think your royalty assumption might be a bit generous. I'm not an expert in the field, but from what I've seen in the past, a 3-5% royalty seams to be the range for a non-exclusive, non-participating patantee in the biomedical field.
Here you will see a dose of Agriflu is sold for about $13:
https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/2011/2011-01-01.html
So applying the high side of that royalty range at 5% to the $13/dose translates to $0.65 per dose.
As the saying goes, "Hope for the best, but be prepared for the worst", I personally believe we have a winnable case, but think the damages will come in more in the $50M range in Texas....which is still a huge windfall for a stock currently valued at about $45 Million! (accounting for full conversion of all debuntures).